This article responds to Arianne Shahvisi’s editorial, which calls for the examination of the war in Gaza with the lenses of distributive justice and scarcity of healthcare resources. We argue that ...

Generative artificial intelligence (AI) chatbots such as ChatGPT have several potential clinical applications, but their use for clinical documentation remains underexplored. AI-generated clinical ...

The increasing use of AI in healthcare has sparked debates about responsibility and accountability for AI-related errors. The difficulty in attributing moral responsibility for undesirable outcomes ...

Correspondence to Indira Samantha Elisabeth van der Zande, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P. O. box 85500, Utrecht, Utrecht 3508 GA, Netherlands ...

In my article, I argued against the view that substitute judgements—whether aided by AI-driven patient preference predictors (P4s) or not—can genuinely respect the autonomy of previously competent ...

Mitochondrial replacement therapy has been developed in order to prevent the transmission of mitochondrial mutations, yet it raises ethical concerns, particularly regarding the involvement of ...

The ageing of the global population prompts many countries to appropriately allocate healthcare resources that ensure adequate elder care. Nevertheless, the shortages in and burdens of professional ...

This short piece is a reply to the response Professor Menzel made to the Shelton and Geppert paper, The Limits of Advance Directives in Decision Making Around Food and Nutrition in Patients with ...

The suitability of doctors as agents of assisting dying remains debated, although it is common in many jurisdictions, and forms part of the proposed assisted dying legislation for England and Wales.

This paper examines the integration of artificial intelligence (AI) into cancer screening programmes, focusing on the associated equity challenges and resource allocation implications. While AI ...

The pace of scientific advancements in medicine, driven by artificial intelligence as much as by novel biotechnologies, demands an ever-faster update of professional knowledge from physicians and ...

Given that only a small fraction of patients with cancer exhibits specific markers making them eligible for effective targeted therapies, this paper investigates the justification of treating cancer ...